Annual EBIT
-$147.32 M
-$21.23 M-16.83%
31 December 2023
Summary:
Mirum Pharmaceuticals annual earnings before interest & taxes is currently -$147.32 million, with the most recent change of -$21.23 million (-16.83%) on 31 December 2023. During the last 3 years, it has fallen by -$80.96 million (-122.00%). MIRM annual EBIT is now -180.44% below its all-time high of -$52.21 million.MIRM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$10.30 M
+$10.13 M+49.58%
30 September 2024
Summary:
Mirum Pharmaceuticals quarterly earnings before interest & taxes is currently -$10.30 million, with the most recent change of +$10.13 million (+49.58%) on 30 September 2024. Over the past year, it has increased by +$21.57 million (+67.68%). MIRM quarterly EBIT is now -116.80% below its all-time high of $61.32 million, reached on 31 December 2021.MIRM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$83.69 M
+$9.46 M+10.16%
30 September 2024
Summary:
Mirum Pharmaceuticals TTM earnings before interest & taxes is currently -$83.69 million, with the most recent change of +$9.46 million (+10.16%) on 30 September 2024. Over the past year, it has increased by +$63.63 million (+43.19%). MIRM TTM EBIT is now -128646.15% below its all-time high of -$65.00 thousand, reached on 30 September 2018.MIRM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MIRM EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +67.7% | +43.2% |
| 3 y3 years | -122.0% | -116.8% | -26.1% |
| 5 y5 years | -180.4% | +37.4% | -59.3% |
MIRM EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -122.0% | at low | -116.8% | +85.3% | -154.9% | +47.5% |
| 5 y | 5 years | -180.4% | at low | -116.8% | +85.3% | -154.9% | +49.1% |
| alltime | all time | -180.4% | at low | -116.8% | +85.3% | <-9999.0% | +49.1% |
Mirum Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.30 M(-49.6%) | -$83.69 M(-10.2%) |
| June 2024 | - | -$20.43 M(-3.1%) | -$93.15 M(-34.7%) |
| Mar 2024 | - | -$21.08 M(-33.9%) | -$142.71 M(-3.1%) |
| Dec 2023 | -$147.32 M(+16.8%) | -$31.87 M(+61.2%) | -$147.32 M(-0.0%) |
| Sept 2023 | - | -$19.77 M(-71.8%) | -$147.38 M(-7.5%) |
| June 2023 | - | -$70.00 M(+172.5%) | -$159.34 M(+33.9%) |
| Mar 2023 | - | -$25.69 M(-19.6%) | -$118.96 M(-5.7%) |
| Dec 2022 | -$126.09 M(+90.0%) | -$31.93 M(+0.7%) | -$126.09 M(+284.0%) |
| Sept 2022 | - | -$31.72 M(+7.1%) | -$32.84 M(-22.8%) |
| June 2022 | - | -$29.62 M(-9.8%) | -$42.55 M(-18.2%) |
| Mar 2022 | - | -$32.82 M(-153.5%) | -$52.04 M(-21.6%) |
| Dec 2021 | -$66.36 M | $61.32 M(-248.0%) | -$66.36 M(-59.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | -$41.43 M(+5.9%) | -$164.55 M(+13.8%) |
| June 2021 | - | -$39.11 M(-17.1%) | -$144.63 M(+12.3%) |
| Mar 2021 | - | -$47.15 M(+27.9%) | -$128.77 M(+25.1%) |
| Dec 2020 | -$102.93 M(+95.9%) | -$36.87 M(+71.4%) | -$102.93 M(+24.7%) |
| Sept 2020 | - | -$21.51 M(-7.5%) | -$82.51 M(+7.3%) |
| June 2020 | - | -$23.25 M(+9.1%) | -$76.87 M(+13.6%) |
| Mar 2020 | - | -$21.31 M(+29.5%) | -$67.65 M(+28.8%) |
| Dec 2019 | -$52.53 M | -$16.45 M(+3.7%) | -$52.53 M(+45.6%) |
| Sept 2019 | - | -$15.87 M(+13.1%) | -$36.09 M(+77.9%) |
| June 2019 | - | -$14.03 M(+126.9%) | -$20.28 M(+224.6%) |
| Mar 2019 | - | -$6.18 M(+9413.8%) | -$6.25 M(+9513.8%) |
| Sept 2018 | - | -$65.00 K | -$65.00 K |
FAQ
- What is Mirum Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals quarterly EBIT year-on-year change?
- What is Mirum Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Mirum Pharmaceuticals?
- What is Mirum Pharmaceuticals TTM EBIT year-on-year change?
What is Mirum Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of MIRM is -$147.32 M
What is the all time high annual EBIT for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high annual earnings before interest & taxes is -$52.21 M
What is Mirum Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of MIRM is -$10.30 M
What is the all time high quarterly EBIT for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high quarterly earnings before interest & taxes is $61.32 M
What is Mirum Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, MIRM quarterly earnings before interest & taxes has changed by +$21.57 M (+67.68%)
What is Mirum Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of MIRM is -$83.69 M
What is the all time high TTM EBIT for Mirum Pharmaceuticals?
Mirum Pharmaceuticals all-time high TTM earnings before interest & taxes is -$65.00 K
What is Mirum Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, MIRM TTM earnings before interest & taxes has changed by +$63.63 M (+43.19%)